Cargando…
Symbol Digit Modalities Test: A valid clinical trial endpoint for measuring cognition in multiple sclerosis
BACKGROUND: The need for more robust outcomes in multiple sclerosis (MS) clinical trials has been a main priority of the field for decades. Dissatisfaction with existing measures has led to several consensus meetings and initiatives over the past few decades in hopes of defining and gaining acceptan...
Autores principales: | Strober, Lauren, DeLuca, John, Benedict, Ralph HB, Jacobs, Adam, Cohen, Jeffrey A, Chiaravalloti, Nancy, Hudson, Lynn D, Rudick, Richard A, LaRocca, Nicholas G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826875/ https://www.ncbi.nlm.nih.gov/pubmed/30334474 http://dx.doi.org/10.1177/1352458518808204 |
Ejemplares similares
-
Validity of the Symbol Digit Modalities Test as a cognition performance outcome measure for multiple sclerosis
por: Benedict, Ralph HB, et al.
Publicado: (2017) -
Validity of the timed 25-foot walk as an ambulatory performance outcome measure for multiple sclerosis
por: Motl, Robert W, et al.
Publicado: (2017) -
The Nine-Hole Peg Test as a manual dexterity performance measure for multiple sclerosis
por: Feys, Peter, et al.
Publicado: (2017) -
Validity of low-contrast letter acuity as a visual performance outcome measure for multiple sclerosis
por: Balcer, Laura J, et al.
Publicado: (2017) -
Remote administration of the symbol digit modalities test to individuals with multiple sclerosis is reliable: A short report
por: Eilam-Stock, Tehila, et al.
Publicado: (2021)